Advancing repurposing policy through multi-sectoral collaboration

<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d25383108e87">Drug repurposing holds immense potential for delivering timely and cost-effective therapies, particularly in areas of high unmet medical need. Yet, despite its promise, repurposing remains hindered by fragmented incentives, regulatory ambiguity, and underutilised collaborative potential across sectors. This presentation—grounded in the ongoing REMEDi4ALL initiative—will explore how a concerted, policy-driven, multi-stakeholder approach can unlock the full value of repurposing strategies. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e89">Systemic barriers such as the on-label vs off-label dichotomy, the limitations of current marketing authorisation frameworks, and the challenges in intellectual property and data exclusivity are reviewed. The role of key stakeholders—including academic researchers, funders, regulators, EFPIA, patient organisations, clinicians, and payers—will be considered as part of a dynamic, interdependent ecosystem. Emerging opportunities including the critical role of emerging frameworks such as the EU Pharma Legislation revision, the STAMP repurposing framework, and the REMEDi4ALL Policy Board in shaping a more enabling environment will be highlighted. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e91">The repurposing ecosystem requires new incentive models: publication metrics must give way to broader impact indicators such as regulatory milestones and translational readiness. The presentation will advocate for stronger public-private partnerships, innovative funding mechanisms, and smarter risk-sharing approaches that elevate both generic and originator-driven repurposing. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e93">Ultimately, international alignment and knowledge exchange are essential to bridging the valley of death in translational research. This session aims to catalyse discussion on a sustainable, integrated approach to repurposing—one that is not theoretical, but already underway.

Authors

Publication Details

Published
2025-09-01
DOI
https://doi.org/10.58647/rexpo.25000132.v1
Primary Topic
Sustainability and Climate Change Governance
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Advancing repurposing policy through multi-sectoral collaboration

Martin de Kort
1 links
Sustainability and Climate Change Governance
article

Advancing repurposing policy through multi-sectoral collaboration

Martin de Kort
article en

Abstract

<p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="first" dir="auto" id="d25383108e87">Drug repurposing holds immense potential for delivering timely and cost-effective therapies, particularly in areas of high unmet medical need. Yet, despite its promise, repurposing remains hindered by fragmented incentives, regulatory ambiguity, and underutilised collaborative potential across sectors. This presentation—grounded in the ongoing REMEDi4ALL initiative—will explore how a concerted, policy-driven, multi-stakeholder approach can unlock the full value of repurposing strategies. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e89">Systemic barriers such as the on-label vs off-label dichotomy, the limitations of current marketing authorisation frameworks, and the challenges in intellectual property and data exclusivity are reviewed. The role of key stakeholders—including academic researchers, funders, regulators, EFPIA, patient organisations, clinicians, and payers—will be considered as part of a dynamic, interdependent ecosystem. Emerging opportunities including the critical role of emerging frameworks such as the EU Pharma Legislation revision, the STAMP repurposing framework, and the REMEDi4ALL Policy Board in shaping a more enabling environment will be highlighted. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e91">The repurposing ecosystem requires new incentive models: publication metrics must give way to broader impact indicators such as regulatory milestones and translational readiness. The presentation will advocate for stronger public-private partnerships, innovative funding mechanisms, and smarter risk-sharing approaches that elevate both generic and originator-driven repurposing. <p xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" dir="auto" id="d25383108e93">Ultimately, international alignment and knowledge exchange are essential to bridging the valley of death in translational research. This session aims to catalyse discussion on a sustainable, integrated approach to repurposing—one that is not theoretical, but already underway.

European Commission
Openalex Percentile: Top 78%
Sustainability and Climate Change Governance
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Advancing repurposing policy through multi-sectoral collaboration — Martin de Kort · (2025) | TGRS Research Map | TGRS